News | March 02, 2026
Blue Jet Healthcare breaks ground on Rs. 2,300 crore pharma plant in Andhra Pradesh
The facility is expected to become operational by FY2028-29
The facility is expected to become operational by FY2028-29
The EIR was issued following an inspection of the facility from November 10 to November 21, 2025
The initiative, funded entirely under the company’s CSR programme, is expected to reach over a million lives
Brivaracetam Oral Solution (10 mg/mL) is a prescription antiepileptic drug (anticonvulsant) used for treatment of partial-onset seizures in patients 1 month of age and older
New partnership combines Shilpa Biologicals’ development and manufacturing capabilities with SteinCares’ regional commercialization platform
One of India’s top integrated contract research, development, and manufacturing organizations (CRDMOs) is on a hiring spree
This partnership represents a systemic shift from awareness to large-scale action for 57 lakh children
The project entails a total planned capital expenditure of approximately Rs. 500 - 520 crore
Samsung Health users can now order medicines, book lab tests and online consultations through PharmEasy, along with 6 months of complimentary PharmEasy Plus membership
ANYRA is India’s first indigenously developed Aflibercept 2 mg biosimilar
Subscribe To Our Newsletter & Stay Updated
